☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Mirati Therapeutics
Mirati Therapeutics’ Krazati (adagrasib) Receives EC’s Approval for Advanced Non-Small Cell Lung Cancer (NSCLC)
January 11, 2024
PharmaShots Weekly Snapshots (October 09–13, 2023) _
October 14, 2023
Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advance...
August 13, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
